BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dagnelie PC, Leij-Halfwerk S. Magnetic resonance spectroscopy to study hepatic metabolism in diffuse liver diseases, diabetes and cancer. World J Gastroenterol 2010; 16(13): 1577-1586 [PMID: 20355236 DOI: 10.3748/wjg.v16.i13.1577] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Zhang L, Wang X, He Y, Cao J, Wang K, Lin H, Qu C, Miao J. Regulatory Effects of Functional Soluble Dietary Fiber from Saccharina japonica Byproduct on the Liver of Obese Mice with Type 2 Diabetes Mellitus. Marine Drugs 2022;20:91. [DOI: 10.3390/md20020091] [Reference Citation Analysis]
2 Ostojic SM, Korovljev D, Stajer V. Dietary intake of creatine and risk of medical conditions in U.S. older men and women: Data from the 2017-2018 National Health and Nutrition Examination Survey. Food Sci Nutr 2021;9:5746-54. [PMID: 34646542 DOI: 10.1002/fsn3.2543] [Reference Citation Analysis]
3 Moon CM, Shin SS, Heo SH, Jeong YY. Metabolic Alterations Associated with Early-Stage Hepatocellular Carcinoma and Their Correlation with Aging and Enzymatic Activity in Patients with Viral Hepatitis-Induced Liver Cirrhosis: A Preliminary Study. J Clin Med 2020;9:E765. [PMID: 32178316 DOI: 10.3390/jcm9030765] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
4 Buchard B, Boirie Y, Cassagnes L, Lamblin G, Coilly A, Abergel A. Assessment of Malnutrition, Sarcopenia and Frailty in Patients with Cirrhosis: Which Tools Should We Use in Clinical Practice? Nutrients. 2020;12:186. [PMID: 31936597 DOI: 10.3390/nu12010186] [Cited by in Crossref: 16] [Cited by in F6Publishing: 32] [Article Influence: 8.0] [Reference Citation Analysis]
5 Tappy L, Rosset R. Health outcomes of a high fructose intake: the importance of physical activity. J Physiol 2019;597:3561-71. [PMID: 31116420 DOI: 10.1113/JP278246] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
6 Busato A, Fumene Feruglio P, Parnigotto PP, Marzola P, Sbarbati A. In vivo imaging techniques: a new era for histochemical analysis. Eur J Histochem 2016;60:2725. [PMID: 28076937 DOI: 10.4081/ejh.2016.2725] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
7 Yaligar J, Teoh WW, Othman R, Verma SK, Phang BH, Lee SS, Wang WW, Toh HC, Gopalan V, Sabapathy K, Velan SS. Longitudinal metabolic imaging of hepatocellular carcinoma in transgenic mouse models identifies acylcarnitine as a potential biomarker for early detection. Sci Rep 2016;6:20299. [PMID: 26831370 DOI: 10.1038/srep20299] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
8 Zhang B, Ding F, Chen T, Xia LH, Qian J, Lv GY. Ultrasound hepatic/renal ratio and hepatic attenuation rate for quantifying liver fat content. World J Gastroenterol 2014; 20(47): 17985-17992 [PMID: 25548498 DOI: 10.3748/wjg.v20.i47.17985] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
9 Shen YC, Ou DL, Hsu C, Lin KL, Chang CY, Lin CY, Liu SH, Cheng AL. Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma. Br J Cancer. 2013;108:72-81. [PMID: 23257894 DOI: 10.1038/bjc.2012.559] [Cited by in Crossref: 120] [Cited by in F6Publishing: 125] [Article Influence: 12.0] [Reference Citation Analysis]
10 Shen ZW, Cao Z, You KZ, Yang ZX, Xiao YY, Cheng XF, Chen YW, Wu RH. Quantification of choline concentration following liver cell apoptosis using 1H magnetic resonance spectroscopy. World J Gastroenterol 2012; 18(10): 1130-1136 [PMID: 22416190 DOI: 10.3748/wjg.v18.i10.1130] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
11 Panda A, Jones S, Stark H, Raghavan RS, Sandrasegaran K, Bansal N, Dydak U. Phosphorus liver MRSI at 3 T using a novel dual-tuned eight-channel ³¹P/¹H H coil. Magn Reson Med 2012;68:1346-56. [PMID: 22287206 DOI: 10.1002/mrm.24164] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
12 Dong H, Lu F, Wang N, Zou X, Rao J. Type 2 diabetic patients with non-alcoholic fatty liver disease exhibit significant haemorheological abnormalities. Front Med 2011;5:288-93. [DOI: 10.1007/s11684-011-0127-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
13 Koh DM, Padhani AR. Functional magnetic resonance imaging of the liver: parametric assessments beyond morphology. Magn Reson Imaging Clin N Am 2010;18:565-85, xii. [PMID: 21094456 DOI: 10.1016/j.mric.2010.07.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
14 Wang L. Morphological and functional MDCT: problem-solving tool and surrogate biomarker for hepatic disease clinical care and drug discovery in the era of personalized medicine. Hepat Med 2010;2:111-24. [PMID: 24367211 DOI: 10.2147/HMER.S9052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
15 Sijens PE. Liver magnetic resonance imaging: State of the art. World J Gastroenterol 2010; 16(13): 1558-1559 [PMID: 20355233 DOI: 10.3748/wjg.v16.i13.1558] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]